日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pattern of progression and post-progression survival following transarterial embolisation: An analysis of the TACE-2 and TACTICS trials

经动脉栓塞术后疾病进展模式及进展后生存情况:TACE-2 和 TACTICS 试验分析

Yuan-Doré, Jack Shi Jie; Rashid, Memuna; Ueshima, Kazuomi; Lopes, Andre; Ma, Yuk Ting; Ross, Paul; Palmer, Daniel; Kudo, Masatoshi; Meyer, Tim

Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma

肝细胞癌经动脉化疗栓塞术患者肝脏最大容量评估的安全性和可行性

Clarke, George; Dhanaraj, Sofi; Hull, Diana; Panton, Michelle; Mergental, Hynek; Afford, Simon C; Shetty, Shishir; Karkhanis, Salil; Mehrzad, Homoyon; Ma, Yuk Ting; Punia, Pankaj; Shah, Tahir; Dasari, Bobby V M

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

胰腺腺癌:ESPAC4 III期试验中辅助治疗的长期结果

Palmer, Daniel H; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula; Rawcliffe, Charlotte; Halloran, Christopher M; Faluyi, Olusola; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Ma, Yuk Ting; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Hammel, Pascal; Borg, David; Sothi, Sharmila; Valle, Juan W; Mehrabi, Arianeb; Bailey, Peter; Tjaden, Christine; Michalski, Christoph; Hackert, Thilo; Büchler, Markus W; Neoptolemos, John P

Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial.

在肝细胞癌患者中,将树突状细胞疫苗接种添加到环磷酰胺预处理和化疗栓塞治疗中:ImmunoTACE 试验

Ma Yuk Ting, Zuo Jianmin, Kirkham Amanda, Curbishley Stuart, Blahova Miroslava, Rowe Anna L, Bathurst Camilla, Mehrzad Homoyoon, Karkhanis Salil, Punia Pankaj, James Martin W, Stern Nick, Rao Ankit, Hull Diana, Lowe Faye, Sylla Panagiota, Webster Luke, Hussain Syed, Yap Christina, Palmer Daniel, Adams David H

UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme

英国通过早期准入计划提供的真实世界证据表明,度伐利尤单抗联合顺铂和吉西他滨可用于治疗晚期胆道癌。

Daniels, Harry; Hassan, Mona; Babiker, Omer; Rowley, William; Qaisar, Aitzaz; Phillips, Emma; Griffin, Ellana; Bell, Catherine; Baraka, Bahaaeldin; Acharige, Shyamika; Aquino, Maia; Plant, Rachel; Mencel, Justin; Chan, Samuel; Parslow, Dominique; Arora, Arvind; Scott-Brown, Martin; Khakoo, Shelize; Braconi, Chiara; Palmer, Daniel; Ma, Yuk Ting; Sivakumar, Shivan

Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma

营养刺激激素疗法:预防和治疗MASH相关肝细胞癌的新前沿

Phillips, Richard; Ma, Yuk Ting; Hanif, Wasim; Shah, Tahir; Sivakumar, Shivan

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine

ABC-12:一项一线研究,旨在探索晚期胆道癌患者接受度伐利尤单抗(MEDI4736)联合顺铂/吉西他滨治疗后的微生物组变化。

Vrana, Eleni; Timmins, Hayley; Osborne, Ashley; Cox, Rebecca; Wasan, Harpreet; Ma, Yuk Ting; Arora, Arvind; Faluyi, Olusola; Gillmore, Roopinder; Corrie, Pippa; Miller, Paul; Arif, Seema; Canham, Joanna; Martin, Charlotte; Riaz, Muhammad; Shi, Tongtong; Frizziero, Melissa; Foy, Victoria; Hubner, Richard A; Morement, Helen; Bridgewater, John; Adams, Richard; Valle, Juan W; McNamara, Mairéad G

SIMAP500: A novel risk score to identify recipients at higher risk of hepatocellular carcinoma recurrence following liver transplantation

SIMAP500:一种用于识别肝移植后肝细胞癌复发风险较高受者的新型风险评分

Alnagar, Amr; Zakeri, Nekisa; Koilias, Konstantinos; Faulkes, Rosemary E; Brown, Rachel; Cain, Owen; Perera, M Thamara P R; Roberts, Keith J; Sanabria-Mateos, Rebeca; Bartlett, David C; Ma, Yuk Ting; Sivakumar, Shivan; Shetty, Shishir; Shah, Tahir; Dasari, Bobby V M

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

经动脉栓塞术(TAE)与经动脉化疗栓塞术(TACE)治疗肝细胞癌的疗效比较:系统评价和荟萃分析

Lawson, Alexander; Kamarajah, Sivesh K; Parente, Alessandro; Pufal, Kamil; Sundareyan, Ramanivas; Pawlik, Timothy M; Ma, Yuk Ting; Shah, Tahir; Kharkhanis, Salil; Dasari, Bobby V M

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

二线FOLFOX化疗与积极症状控制治疗晚期胆道癌的疗效比较(ABC-06):一项3期、开放标签、随机、对照试验

Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John; Davies, Linda M; Bridgewater, John A; Valle, Juan W